Reduced renal dopamine D1 receptor function in streptozotocin-induced diabetic rats

American Journal of Physiology - Renal Physiology

Volumn 286, Issue 3 55-3, 2004, Pages

  Marwaha, Aditi ^a   Banday, Anees Ahmad ^a   Lokhandwala, Mustafa F ^a  

^a UNIVERSITY OF HOUSTON   (United States)

Author keywords

G proteins; Hyperglycemia; Na K ATPase; Natriuresis; SKF 38393

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); DOPAMINE 1 RECEPTOR; DOPAMINE 1 RECEPTOR STIMULATING AGENT; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); SULFUR 35; TRITIUM;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DOPAMINERGIC SYSTEM; ENZYME ACTIVITY; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FUNCTION; KIDNEY PROXIMAL TUBULE; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES; URINALYSIS; WESTERN BLOTTING;

EID: 1242329249     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00227.2003     Document Type: Article

References (40)

1. Aperia A, Fryckstedt J, Holtback U, Belusa R, Cheng XJ, Eklof AC, Li D, Wang ZM, and Ohtomo Y. Cellular mechanisms for bi-directional regulation of tubular sodium reabsorption. Kidney Int 49: 1743-1747, 1996.
2. Aperia AC. Intrarenal dopamine: a key signal in the interactive regulation of sodium metabolism. Annu Rev Physiol 62: 621-647, 2000.
3. Banday AA, Asghar M, Hussain T, and Lokhandwala MF. Dopamine-mediated inhibition of renal Na,K-ATPase is reduced by insulin. Hypertension 41: 1353-1358, 2003.
4. Blandini F, Fancellu R, Orzi F, Conti G, Greco R, Tassorelli C, and Nappi G. Selective stimulation of striatal dopamine receptors of the D1-or D2-class causes opposite changes of fos expression in the rat cerebral cortex. Eur J Neurosci 17: 763-770, 2003.
5. Carranza A, Karabatas L, Barontini M, and Armando I. Decreased tubular uptake of L-3, 4-dihydroxyphenylalanine in streptozotocin-induced diabetic rats. Horm Res 55: 282-287, 2001.
6. Chen C, Beach RE, and Lokhandwala MF. Dopamine fails to inhibit renal tubular sodium pump in hypertensive rats. Hypertension 21: 364-372, 1993.
7. Hegde SS, Jadhav AL, and Lokhandwala MF. Role of kidney dopamine in the natriuretic response to volume expansion in rats. Hypertension 13: 828-834, 1989.
8. Holtback U, Brismar H, DiBona GF, Fu M, Greengard P, and Aperia A. Receptor recruitment: a mechanism for interactions between G protein-coupled receptors. Proc Natl Acad Sci USA 96: 7271-7275, 1991.
9. +-ATPase in renal proximal tubules via the cAMP pathway. Eur J Pharmacol 321: 259-263, 1997.
10. Hussain T, Becker M, Beheray S, and Lokhandwala MF. Dopamine fails to inhibit Na,H-exchanger in proximal tubules of obese Zucker rats. Clin Exp Hypertens 23: 591-601, 2001.
11. Hussain T, Beheray SA, and Lokhandwala MF. Defective dopamine receptor function in proximal tubules of obese Zucker rats. Hypertension 34: 1091-1096, 1999.
12. q/11 proteins in spontaneously hypertensive rats. Am J Physiol Renal Physiol 272: F339-F346, 1997.
13. Hussain T and Lokhandwala MF. Renal dopamine receptors and hypertension. Exp Biol Med 228: 134-142, 2003.
14. Jose PA, Eisner GM, and Felder RA. Renal dopamine and sodium homeostasis. Curr Hypertens Rep 2: 174-183, 2000.
15. Kansra V, Hussain T, and Lokhandwala MF, Alterations in dopamine DA1 receptor and G proteins in renal proximal tubules of old rats. Am J Physiol Renal Physiol 273: F53-F59, 1997.
16. Khadouri C, Barlet-Bas C, and Doucet A. Mechanism of increased tubular Na-K-ATPase during streptozotocin-induced diabetes. Pflügers Arch 409: 296-301, 1987.
17. +-adenosine triphosphatase in streptozotocin-diabetic rats. J Pharmacol Exp Ther 229: 664-670, 1984.
18. Ku DD, Sellers BM, and Meezan E. Development of renal hypertrophy and increased renal Na,K-ATPase in streptozotocin-diabetic rats. Endocrinology 119: 672-679, 1986.
19. Lal MA, Korner A, Matsuo Y, Zelenin S, Cheng SX, Jaremko G, DiBona GF, Eklof AC, and Aperia A. Combined antioxidant and COMT inhibitor treatment reverses renal abnormalities in diabetic rats. Diabetes 49: 1381-1389, 2000.
20. Lin S, Kajimura M, Takeuchi K, Kodaira M, Hanai H, Nishimura M, and Kaneko E. Alterations of GTP-binding proteins (Gsα and Gq/11α) in gastric smooth muscle cells from streptozotocin-induced and WBN/Kob diabetic rats. Dig Dis Sci 45: 1517-1524, 2000.
21. Madacsy L, Sulyok E, Klujber L, Vamosi I, Barkai L, and Baranyai Z. Decreased urinary excretion of dopamine and sodium in diabetic children with incipient nephropathy. Padiatr Padol 26: 253-256, 1991.
22. Miller JA. Impact of hyperglycemia on the renin angiotensin system in early human type 1 diabetes mellitus. J Am Soc Nephrol 10: 1778-1785, 1999.
23. O'Hare JP, Roland JM, Walters G, and Corrall RJ. Impaired sodium excretion in response to volume expansion induced by water immersion in insulin-dependent diabetes mellitus. Clin Sci (Lond) 71: 403-409, 1986.
24. Ozturk Y, Altan VM, and Yildizoglu-Ari N. Effects of experimental diabetes and insulin on smooth muscle functions. Pharmacol Rev 48: 69-112, 1996.
25. Patel KP and Zhang PL. Attenuated renal responses to atrial natriuretic factor in streptozotocin-induced diabetic rats. Can J Physiol Pharmacol 68: 425-430, 1990.
26. Patel KP and Zhang PL. Reduced renal responses to volume expansion in streptozotocin-induced diabetic rats. Am J Physiol Regul Integr Comp Physiol 257: R672-R679, 1989.
27. +-stimulated AT-Pase activity in rat intestinal mucosa. Biochim Biophys Acta 173: 456-468, 1969.
28. Roysommuti S, Khongnakha T, Jirakulsomchok D, and Wyss JM. Excess dietary glucose alters renal function before increasing arterial pressure and inducing insulin resistance. Am J Hypertens 15: 773-779, 2002.
29. Rutledge LP, Ngong JM, Kuperberg JM, Samaan SS, Soliman KF, and Kolta MG. Dopaminergic system modulation of nociceptive response in long-term diabetic rats. Pharmacol Biochem Behav 74: 1-9, 2002.
30. 1 receptor-mediated locomotor-enhancing activity in mice. Pharmacol Biochem Behav 60: 161-166, 1998.
31. 1 dopamine receptor in alloxan-induced diabetes. Diabetes 41: 1119-1121, 1992.
32. Saller CF and Chiodo LA. Glucose suppresses basal firing and haloperidol-induced increases in the firing rate of central dopaminergic neurons. Science 210: 1269-1271, 1980.
33. Sandyk R. The relationship between diabetes mellitus and Parkinson's disease. Int J Neurosci 69: 125-130, 1993.
34. 2-dopamine receptor activation on melatonin synthesis in bovine pinealocytes. J Pineal Res 35: 169-176, 2003.
35. Stenvinkel P, Saggar-Malik AK, and Alvestrand A. Renal haemodynamics and tubular sodium handling following volume expansion with sodium chloride (NaCl) and glucose in healthy humans. Scand J Clin Lab Invest 52: 837-846, 1992.
36. Stenvinkel P, Saggar-Malik AK, Wahrenberg H, Diczfalusy U, Bolinder J, and Alvestrand A. Impaired intrarenal dopamine production following intravenous sodium chloride infusion in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 34: 114-118, 1991.
37. Umrani DN, Banday AA, Hussain T, and Lokhandwala MF. Rosiglitazone treatment restores renal dopamine receptor function in obese Zucker rats. Hypertension 40: 880-885, 2002.
38. +-ATPase activity. Pflügers Arch 401: 97-100, 1984.
39. 3 dopamine receptors in renal proximal tubule cells of SHR. Hypertension 41: 724-729, 2003.
40. Zimpelmann J, Kumar D, Levine DZ, Wehbi G, Imig JD, Navar LG, and Burns KD. Early diabetes mellitus stimulates proximal tubule renin mRNA expression in the rat. Kidney Int 58: 2320-2330, 2000.